LLMpediaThe first transparent, open encyclopedia generated by LLMs

Cochrane Library

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Coral Triangle Hop 4
Expansion Funnel Raw 94 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted94
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Cochrane Library
Cochrane Library
NameCochrane Library
TypeMedical database
OwnerCochrane
Founded1993
CountryUnited Kingdom

Cochrane Library

The Cochrane Library is an online collection of evidence-based medicine resources, notable for its systematic reviews and meta-analyses. It serves clinicians, policymakers, and researchers by aggregating trial data and review syntheses to inform decisions in contexts such as clinical practice guidelines, health technology assessment, and public health programs. The platform operates within a networked ecosystem that includes research centres, learned societies, and funding bodies.

Overview

The Library comprises curated collections of randomized controlled trials, systematic reviews, and clinical trials registries maintained by an international collaboration of contributors from institutions such as University of Oxford, Harvard University, World Health Organization, National Institute for Health and Care Excellence, and Johns Hopkins University. Stakeholders include authors affiliated with Karolinska Institutet, University of Toronto, Imperial College London, McMaster University, and University College London. Users range from clinicians at Mayo Clinic and Cleveland Clinic to policymakers at European Commission and United States Congress committees. The platform is linked with registries and databases like PubMed, Embase, ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, and MEDLINE.

History and Development

Originating in the early 1990s, the initiative drew on methodological advances promoted by figures and groups such as Iain Chalmers, Archie Cochrane, David Sackett, Cochrane Collaboration founders, and institutions including Oxford University Press and Addison-Wesley. Early funding and partnerships involved organizations like Wellcome Trust, Rockefeller Foundation, European Commission, US National Library of Medicine, and Canadian Institutes of Health Research. Milestones involved integration with platforms run by BMJ Publishing Group, Wiley-Blackwell, and collaborations with Cochrane Centre networks in regions such as Australia, Canada, Brazil, South Africa, and India. Subsequent developments intersected with guideline-producing bodies including World Health Organization guideline panels, National Health Service committees, and specialist societies like American College of Physicians.

Structure and Content

The content architecture includes repositories of systematic reviews, individual participant data meta-analyses, and trial registers produced by review groups associated with academic partners such as Karolinska Institutet, University of Melbourne, University of Sydney, University of Edinburgh, and McMaster University. The Library indexes trials from sources including PubMed Central, CINAHL, Scopus, PsycINFO, and Web of Science. Editorial governance involves editorial teams drawn from Royal Society of Medicine, Academy of Medical Sciences, and national research institutes like National Institutes of Health and Institut Pasteur. Specialized review groups cover clinical areas reflected in organizations such as American Heart Association, European Respiratory Society, International Diabetes Federation, American Psychiatric Association, and American Society of Clinical Oncology.

Access and Subscription Models

Access models have varied through partnerships with publishers including Wiley, BMJ Group, and consortia such as Research4Life and national license initiatives in countries represented by German Research Foundation, Australian Research Council, Canadian Research Knowledge Network, and Jisc. Subscription tiers include institutional subscriptions used by universities like Stanford University and hospitals like Massachusetts General Hospital, as well as national site licences negotiated with ministries akin to Department of Health and Social Care (UK)-level agreements. Open access policies intersect with funders such as Wellcome Trust, Bill & Melinda Gates Foundation, European Research Council, and mandates originating from National Institutes of Health paylines.

Methodology and Quality Assurance

Methodological standards align with guidance from figures and entities such as David Sackett, Iain Chalmers, Guyatt GRADE Working Group, GRADE Working Group, CONSORT, and organizations including Institute of Medicine and Cochrane Methodology Review Group partners at universities like McMaster University and King's College London. Quality assurance includes peer review mechanisms involving editorial boards tied to Royal College of Physicians, statistical oversight from biostatisticians associated with Johns Hopkins Bloomberg School of Public Health and London School of Hygiene & Tropical Medicine, and conflict of interest policies reflecting standards from World Health Organization and European Medicines Agency. Data synthesis methods reference practices used by groups at Agency for Healthcare Research and Quality and National Institute for Health and Care Excellence guideline units.

Impact and Criticism

The Library's syntheses have influenced landmark guidelines and policy decisions in contexts linked to National Institute for Health and Care Excellence, World Health Organization, Centers for Disease Control and Prevention, European Medicines Agency, and Pan American Health Organization. Its reviews have been cited in influential works from agencies like US Preventive Services Task Force and journals including The Lancet, BMJ, New England Journal of Medicine, and JAMA. Criticisms have come from researchers at institutions such as University of California, San Francisco and Harvard School of Public Health concerning issues like publication bias, resource constraints, and timeliness relative to rapid-response needs during crises exemplified by responses to Ebola virus epidemic and COVID-19 pandemic. Debates involve stakeholders including pharmaceutical industry representatives, patient advocacy groups like PatientsLikeMe, and health technology assessment panels at bodies such as Canadian Agency for Drugs and Technologies in Health.

Category:Medical databases